Our board

Bruce Rosengarten

Chairman

Bruce Rosengarten has spent over 35 years in executive roles across eminent organisations, and has been living with ulcerative colitis for more than 40 years. Until mid-2017, Bruce was Executive General Manager, Commercial at Caltex responsible for all sales,marketing, innovation and convenience stores. Bruce has held senior roles at Weight Watchers (President Asia Pacific and emerging markets) at Shell (Global Vice President Retail, Marketing) where he led Fuels, Convenience stores, Loyalty, Cards, Marketing and the Shell brand globally. Prior, he was Executive Director at Crown launching Crown locally and internationally and running Tables Games. He spent over 12 years at Coles Myer running regions of Department stores and as Managing Director of World 4 Kids.

Bruce has extensive governance experience across a diverse range of organisations including ASX listed, private companies, joint ventures, industry associations and not for profit. Bruce was a Director of Jewish Care Vic 2008-15 and its President/Chair 2009-2012. He has held governance roles in not profit sector including the Singapore Jewish Welfare Board and as a Council Member of Mt Scopus Memorial College. He has also held extensive roles in industry associations including International Committee Chair National Association of Convenience Stores, Australian Institute of Petroleum, VP South Australian Retailer’s Association, Rundle Mall Management Committee Member.

Bruce is the author of Passionate Leadership, runs his own consultancy and is a member of several advisory Boards: Binyan 3D Studios (Chairman), Link Financial Services (Chairman) and MadMex.

Greg Moore

Director

Associate Professor Greg Moore is an IBD specialist gastroenterologist. He founded the Inflammatory Bowel Diseases Unit at Monash Medical Centre in 2006 and oversees a specialised IBD clinic. Greg coordinates a busy clinical trials unit, undertakes ongoing research and combines private practice and undergraduate and post-graduate teaching.

He is a senior lecturer in the Department of Medicine Monash University and supervises research students. Greg is also a member of Australian Inflammatory Bowel Disease Association, the peak medical IBD group, and is a sought after speaker at both scientific and public forums.

Kara Ward

Director

Kara Ward is a digital experience strategist and marketer. She has over 25 years experience designing and leading transformation programs for start-ups, joint ventures, non-profits, government agencies, and global corporations.

As one of the early pioneers of digital, Kara launched significant brands in the Australian market including Microsoft, Telstra, and Nine Digital. She has brought new products and services to market, and established profitable revenue streams for multinationals such as Macquarie Bank, Westpac, Merrill Lynch, and Insurance Australia Group.

Kara has worked for the top two globally ranked leaders in digital, Accenture Interactive and Wunderman, and instructed the business leaders of tomorrow at General Assembly. She runs a digital strategy and management consulting business. Kara has family and friends living with Crohn’s disease.

Kate McQuestin

Director

Kate McQuestin is the CEO of Advance Global Australians. She is a public and private sector executive with more than 20 years experience in leadership, government, media, communications, public affairs and stakeholder engagement.

A skilled executive who has worked and lived in the United States of America, United Kingdom, Europe, Japan and Australia. Born and educated in Tasmania, Kate was diagnosed with thyroid cancer at age 14 and subsequently Crohn’s disease.

Her goal, as a Non-Executive Director, is to have a meaningful impact at a strategic level, while increasing community understanding of the condition, making life-changing medicine more accessible and improving outcomes for others who are diagnosed.

Bruce Goodwin

Director

Bruce Goodwin has more than 35 years of experience in the Global Biopharmaceutical industry having previously been employed by the Janssen Pharmaceutical Companies of Johnson & Johnson. His tenure with Janssen included more than a decade in General Management roles including Managing Director Janssen Australia & New Zealand, as well as President & Representative Director Janssen Japan. He has overseen significant commercial success, and he has deep experience in organizational strategy as well as building and engaging talent.

Bruce is a respected Industry Leader and is currently a Selected Director and Board Member of Medicines Australia Limited. Whilst in Japan he served as the Vice Chair of the Japan Based Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA).

Through his multiple non-executive Director roles, Bruce seeks to contribute to the development of innovation in healthcare and equality of access to treatments. He was appointed Director and Board member of the Australian Genomic Cancer Medicine Centre Limited (Omico) in 2018, Rare Cancers Australia Limited in 2020, and most recently Delica Therapeutics Pty Limited in 2021.

He holds a Bachelor’s Degree in Economics and a Masters Degree in Business Administration from Macquarie University, and is also a graduate of the Australian Institute of Company Directors.

Lisa Neville

Director

Lisa is the former Minister for Police and the Minister for Water in the Andrews Labor Government of Victoria.

Lisa took on the police portfolio in 2016 and since then has implemented a new strategic policy framework for community safety which is driving the biggest expansion in police numbers, technology and equipment in the force’s history.

She maintains a keen interest in issues and services for women and children, people with a disability and older Victorians.

Lisa was diagnosed with Crohn’s disease in 1988, and like most people with Crohn’s, it took a while for medical professionals to correctly identify the disease.

Living with Crohn’s has meant many flare ups, surgeries, and complications – all side-effects of the disease that patients will know well.

In 2021, she experienced a major health scare which required an extended period of leave.

Prior to this episode, Lisa had managed Crohn’s very privately but her experience – particularly hearing from so many fellow Crohn’s sufferers – reinforced to her the importance of talking openly about this terrible this disease and the impact it has.

Lisa is proud to be an ambassador for Crohn’s & Colitis Australia and hopes to give inspiration to people by speaking out about this this silent and often invisible disease that impacts thousands of Australians every day.